CNS
Overvalued by 53.3% based on the discounted cash flow analysis.
Market cap | $3.98 Billion |
---|---|
Enterprise Value | $3.93 Billion |
Dividend Yield | $2.42 (3.1021663889245%) |
Earnings per Share | $3 |
Beta | 1.32 |
Outstanding Shares | 51,058,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 25.36 |
---|---|
PEG | 149.37 |
Price to Sales | 7.8 |
Price to Book Ratio | 6.5 |
Enterprise Value to Revenue | 7.05 |
Enterprise Value to EBIT | 19.31 |
Enterprise Value to Net Income | 24 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.03 |
No data
No data